Introduction {#Sec1}
============

The shoulder is a unique anatomical structure with an extraordinary range of motion (ROM) that allows us to interact with our environment. A loss of mobility of this joint will cause significant morbidity. Adhesive capsulitis is a poorly understood musculoskeletal condition that can be disabling. Adhesive capsulitis is diagnosed by numerous physical characteristics including a thickening of the synovial capsule, adhesions within the subacromial or subdeltoid bursa, adhesions to the biceps tendon, and/or obliteration of the axillary fold secondary to adhesions \[[@CR1]--[@CR9]\]. Since Duplay initially described a case report of adhesive capsulitis almost 130 years ago, this condition remains an enigmatic shoulder disorder that causes pain and restricted ROM at the glenohumeral joint \[[@CR10]\].

Incidence {#Sec2}
=========

Adhesive capsulitis has an incidence of 3--5% in the general population and up to 20% in those with diabetes. This disorder is one of the most common musculoskeletal problems seen in orthopedics \[[@CR11]--[@CR15]\]. Although some have described adhesive capsulitis as a self-limiting disorder that resolves in 1--3 years \[[@CR13], [@CR16]--[@CR20]\], other studies report ranges of between 20 and 50% of patients with adhesive caspulitis which suffer long-term ROM deficits that may last up to 10 years \[[@CR21]--[@CR25]\].

The typical patient that develops adhesive capsulitis is a female in her 5th to 7th decade of life \[[@CR17], [@CR23]\]. There is generally no preference for handedness and adhesive capsulitis rarely occurs simultaneously bilaterally \[[@CR17], [@CR23]\]. However, others have reported that it can occur sequentially bilaterally in up to 40--50% of patients \[[@CR26]\]. Adhesive capsulitis is commonly associated with other systemic and nonsystemic conditions. By far the most common is the co-morbid condition of diabetes mellitus, with an incidence of 10--36% \[[@CR14], [@CR27], [@CR28]\].

Other co-morbid conditions include hyperthyroidism, hypothyroidism, hypoadrenalism, Parkinson's disease, cardiac disease, pulmonary disease, stroke, and even surgical procedures that do not affect the shoulder such as cardiac surgery, cardiac catheterization, neurosurgery, and radical neck dissection \[[@CR29]--[@CR39]\].

Wolf and Green \[[@CR40]\] prospectively evaluated 100 consecutive patients with adhesive capsulitis with use of several forms of questionnaires. Patients with more comorbidities had significantly lower and poorer scores on shoulder assessment forms, social function, and emotional and mental health.

Adhesive capsulitis classification {#Sec3}
==================================

Adhesive capsulitis is classified into two categories: (1) primary, which is insidious and idiopathic, or (2) secondary, which is generally due to trauma or subsequent immobilization \[[@CR41]\]. Those with primary adhesive capsulitis generally have a very gradual onset and progression of symptoms, with no known precipitating event that can be identified \[[@CR42]\]. These symptoms may progress so slowly that the patient does not even seek medical attention until ROM and pain severely limit their daily activities. It is not uncommon for a patient to present with shoulder pain as their only complaint and not realize there is a loss of motion. This is unlike the person afflicted with a secondary adhesive capsulitis who usually notices their symptoms soon after a fall or inciting trauma as their ROM does not appear to improve as expected after the pain from the inciting event should no longer limit ROM.

Clinical phases {#Sec4}
===============

Adhesive capsulitis presentation is generally broken into three distinct stages \[[@CR43]\]. The first stage that is described is called the *freezing or painful stage*. Patients may not present during this stage because they think that eventually the pain will resolve if self-treated. As the symptoms progress, pain worsens and both active and passive ROM becomes more restricted, eventually resulting in the patient seeking medical consultation. This phase typically lasts between 3 and 9 months and is characterized by an acute synovitis of the glenohumeral joint \[[@CR44]\].

Most patients will progress to the second stage, the *frozen or transitional stage.* During this stage shoulder pain does not necessarily worsen. Because of pain at end ROM, use of the arm may be limited causing muscular disuse. The frozen stage lasts anywhere 4 to 12 months \[[@CR44]\]. The common capsular pattern of limitation has historically been described as diminishing motions with external shoulder rotation being the most limited, followed closely by shoulder flexion, and internal rotation. There eventually becomes a point in the frozen stage that pain does not occur at the end of ROM.

The third stage begins when ROM begins to improve. This 3rd stage is termed the *thawing stage*. This stage lasts anywhere from 12 to 42 months and is defined by a gradual return of shoulder mobility.

Pathology {#Sec5}
=========

Pain associated with adhesive capsulitis can cause a limitation or selective immobilization of the painful shoulder. Prolonged immobilization of a joint has been shown to cause several detrimental pathophysiologic findings including: decreased collagen length, fibrofatty infiltration into the capsular recess, ligament atrophy resulting in decreased stress absorption, collagen band bridging across recesses, random collagen production, and altered sarcomere number in muscle tissue \[[@CR45]\].

Evaluation {#Sec6}
==========

The evaluation of adhesive capsulitis starts with a thorough shoulder history. Inciting events such as mild trauma are often given in relation to the shoulder pain. This may be something very trivial, and in fact may not be related to the process, but the patient may recall something that is attributed to starting the process. Adhesive capsulitis often involves the non-dominant extremity. This is because it is easier to protect and not use the extremity because it is painful and the dominant extremity can do the work. When the extremity is held close to the body, often to "protect it", the process can then proceed unchecked. This becomes even more apparent when passive ROM is accompanied by an unusual amount of pain and guarding. Codman \[[@CR18]\] discussed this entity describing a slow onset of pain, felt near the insertion of the deltoid, inability to sleep on the affected side, and restriction in both active and passive elevation as well as external rotation, yet with normal radiologic appearance. Without degenerative joint disease on radiographs, this clinical picture suggests the diagnosis of adhesive capsulitis.

The physical examination is marked by the loss of both passive and active range of motion. This motion may also be painful as the capsule reaches its stretching point. Examination tests for other shoulder abnormalities can also be positive. Testing for impingement may be positive with a Hawkin's or Neer sign; however, the pain is likely from the intrinsic process of impingement or capsular stretch rather than from adhesive capsulitis.

The diagnosis of adhesive capsulitis is often one of exclusion. Early in the disease process adhesive capsulitis may clinically appear similar to other shoulder conditions such as major trauma, rotator cuff tear, rotator cuff contusion, labral tear, bone contusion, subacromial bursitis, cervical or peripheral neuropathy. Additionally, a history of a previous surgical procedure can lead to shoulder stiffness*.* If a history of these other pathologies are negative and if radiographs do not demonstrate osteoarthritis, then the diagnosis can be given.

A screening radiograph of the shoulder is imperative to diagnose adhesive capsulitis. This rules out other possible diagnosis of loss of ROM that include osteoarthritis, or chronic anterior or posterior dislocation.

Non-operative treatment {#Sec7}
=======================

Anti-inflammatories {#Sec8}
-------------------

Treatment of adhesive capsulitis often involves the use of anti-inflammatories, or corticosteroids. NSAIDs may be used during any phase as an attempt to relieve symptoms. There are no well done studies to indicate that NSAIDs change the natural history of adhesive capsulitis. There is a paucity of literature that even would support the use of NSAIDS for this diagnosis. However, NSAIDS are not only anti-inflammatories, they are analgesics and are a reasonable first choice for treatment.

A summary of studies related to oral corticosteroids can be seen in Table [1](#Tab1){ref-type="table"}. There are no randomized studies comparing oral corticosteroids with placebo or natural history of the condition. Most studies seem to show that corticosteroids may reduce pain early on better than rehabilitation or placebo but their benefits are not maintained long term. Their risks and benefits therefore must be strongly considered before using them since long-term benefit is not supported. They may be considered when short-term gain is necessary for a particular event. Table 1Description of published randomized controlled trials of oral corticosteroids for adhesive capsulitisStudy and date publishedNumber of shouldersActive interventionControl interventionResultsBlockey and Wright \[[@CR62]\], 195432Cortisone acetate (200 mg daily for 3 days, then 100 mg daily for 11 days, then dose tapered off in decrements of 12.5 mg every 2 days, total dose = 2.5 g over 4 weeks. If unsatisfactory progress after 4 weeks, manipulation under general anaesthesia; followed by a second 4 week course of cortisone acetatePlaceboNo statistical analysis of between-group differences reported, although an earlier clinically important improvement in both pain and range of motion was noted in the oral steroid group: mean pain scores (measured on a 4-point categorical scale converted into an interval scale, where none = 0, slight = 1, moderated = 2, severe = 3) at baseline, 1, 4, and 18 weeks were 1.4, 0.9, 0.5, 0.6 in the steroid group, and 1.4, 1.3, 0.8, 0.5 in the control group; total shoulder abduction was 82, 103, 125, 153° in the steroid groups and 75, 89, 106, 154° in the control group. The number of participants requiring manipulation after 4 weeks was 6/15 (40%) and 11/16(68.8%) in the steroid and placebo groups, respectively (RR = 0.58 (0.29--1.17))Kessel et al. \[[@CR63]\], 198132Prednisolone (15 mg daily for 4 weeks) and manipulation (after 2 weeks of oral steroids)ManipulationNo statistical analysis was done but "dramatic response" to manipulation in 7/12 (58.3%) participants taking oral steroids compared with 5/16 (31.25%) taking placebo. Effect of manipulation on final range of motion at 6, 12, and 18 weeks following the procedure also favored the steroid group but again the differences between groups were normally not formally analyzedBinder et al. \[[@CR23]\], 198640Prednisolone (10 mg daily for 4 weeks, then 5 mg daily for 2 weeksNo treatmentThe pattern of improvement in pain at night over 8 weeks showed a significant difference in favor of oral prednisolone with a more rapid initial recovery, although by 5 months the difference between the groups was negligible. Improvement in pain at rest and with movement, range of motion, and a cumulative recovery curve were not significantly different between groups over 8 monthsBuchbinder et al. \[[@CR64]\], 200450Prednisolone (30 mg daily for 3 weeks)PlaceboGreater improvement in overall pain in oral steroid group than in placebo group at 3 weeks. There was also greater improvement in disability, range of motion and participant rated improvement in 22/23 (96%) oral steroid, vs. 11/23 (48%) in placebo group. At 6 weeks, analysis favored the oral steroid group for most outcomes but none of the differences was significant. At 12 weeks, the analysis tended to favor the placebo group. A 3 week course of 30 mg prednisolone daily is of significant short-term benefit in adhesive capsulitis but benefits are not maintained beyond 6 weeks

Intra-articular corticosteroid injections {#Sec9}
-----------------------------------------

Although high-quality randomized studies of corticosteroid injection for treatment of adhesive capsulitis have not been done, there is some evidence to indicate there is a short-term benefit with their use. Given the low likelihood of complications with this approach, the use of either a subacromial injection or glenohumeral injection should be considered. One limitation to using this form of treatment comes upon recent evidence that injections performed blindly may be inaccurate in approximately 60% of cases. Better clinical outcome is found with greater accuracy \[[@CR46], [@CR47]\]. This problem may be overcome with the use of ultrasound guided joint injection. Please see Table [2](#Tab2){ref-type="table"} for studies related to intra-articular cortisone injections for adhesive capsulitis. Table 2Review of trials of injection studies following adhesive capsulitisStudy and dateNumber of shouldersDuration of symptomsInterventions and number of treatmentsOutcomes measuredFollow-upFindings*Randomized clinical trials*Bulgen et al. \[[@CR21]\], 198442∼5 monthsSub acromial corticosteroid injections---11; mobilization---11; ice therapy---12; and control---8Pain\
ROM8 monthsAt 4 weeks improvements in ROM occurred in the group treated with steroids. At 6 months no significant differences were seen between groupsCarette et al. \[[@CR65]\], 200393\<12 monthsSA Injection + 12 PT---21Function6 weeksAt 6 weeks score improved more in groups receiving steroid. Range of motion improved in all groups but with steroid and PT. No difference in saline groups at follow-up sessions. At 12 months all groups improvedSA injection alone---233 monthsSaline injection + 12 PT---266 monthsSaline injection alone---231 yearRyans et al. \[[@CR66]\], 200580\<6 monthsInjection + 8 PT---20Pain\
Function6 weeksFunction improved more in group with injection at 6 weeks. PT improved ER range of motion at 6 weeks. Injection improved function (global) at 6 weeks. At 16 weeks all groups had improved to similar degree with respect to outcomesInjection alone---2016 weeksPlacebo injection + 8 PT---20Placebo injection alone---20van der Windt et al. \[[@CR60]\], 19981085 monthsPhysical therapy---12 treatments vs. 3 corticosteroid intra- articular injectionsPain\
ROM\
Function52 weeksAt 7 weeks 77% treated with injections were considered successes compared with 46% treated with physical therapy. At 26 and 52 weeks these differences in outcome measures were smallWinters et al. \[[@CR59]\], 199711418 monthsPhysical therapy 20 treatments vs. manipulation vs. corticosteroid injections. Injections in either joint capsule, sub acromial space, or AC jointPain11 weeksPatients placed into one of two groups---shoulder group and synovial group. Shoulder girdle group divided into manipulation or physiotherapy, patients in the synovial group divided into corticosteroid injection, manipulation physiotherapy. In shoulder girdle group---manipulation less duration of pain than physiotherapy. In synovial group duration of complaints shortest after corticosteroid injection, followed by manipulation and physiotherapyRizk et al. \[[@CR74]\], 19914813 weeksIntra-articular steroid and lidocaine; intrabursal steroid and lidocaine; intra-articular lidocaine; and intra-busal lidocainePain\
ROM15 weeksNo difference noted in outcome between intrabursal and intra-articular injections. Injection of steroid lidocaine had no advantage over lidocaine alone in restoring motion, but partial, transient pain relief occurred in two-thirds of the steroid- treated patients6 monthsJacobs et al. \[[@CR75]\], 199147Not reportedThree intra-articular injections given over 6 week intervals. Distension vs. distension with steroidROM\
Strength1st visitAll reported improvement. ROM greater in steroid with distension group. Strength did not differ between groups6 weeks12 weeksDacre et al. \[[@CR76]\], 1989664 weeksSteroid injection (22)\
Physiotherapy (20)\
Both (20)Pain\
ROM6 weeksAll groups showed significant improvements by 6 weeks with ER. No further improvement at 6 months. The seen improvements were identical in all groups. Local steroid injections may be as effective as physical therapy alone or a combination of both6 months

Capsular distension injections {#Sec10}
------------------------------

This method of treatment has been described for patients under local anesthesia. The joint is injected to its limits with local anesthetic to attempt to stretch the capsule. This technique is often poorly tolerated because of pain that is experienced during the process as the entire shoulder is not anesthetized from the intra-articular injection \[[@CR48]\].

Surgical treatment {#Sec11}
------------------

The treatment of adhesive capsulitis should lead to the operating room only after a concerted effort at conservative management has failed. There is not a discrete timeline to head to surgery. As a general rule patients should have participated in some form of therapy for at least 2 months, and shown no progress. Patients should feel they are not making progress and have significant pain and limitations of occupation, recreation, or sleep to proceed with surgical intervention.

### Manipulation under anesthesia {#Sec12}

Manipulation under anesthesia as a means of treatment has been advocated. This method allows return of ROM in the operating room. Immediate postoperative physical therapy can be initiated with this form of treatment \[[@CR49]\]. Manipulation under anesthesia has the disadvantage in that tissues that are stretched while the patient is under anesthesia may cause pain when awake. This can potentially slow recovery. When surgical release is added to this procedure it induces further surgical trauma to the shoulder and may slow rehabilitation.

### Arthroscopic release and repair {#Sec13}

Arthroscopy is an excellent additional tool for addressing the shoulder with adhesive capsulitis, and has become well accepted in treating this process. The essential lesion is the tightened coracohumeral ligament and rotator interval with the contracted capsule including the axillary pouch. These structures can be treated by release with arthroscopic instruments. The contracted structures are released to allow ROM to return with manipulation if necessary. The release can be performed either before, during, or after the manipulation with favorable results (Fig. [1](#Fig1){ref-type="fig"}) \[[@CR50]--[@CR60]\]. The manipulation may need to precede the procedure to gain access to the joint. Arthroscopy allows a full evaluation of the shoulder anatomy as well. Any abnormalities that may not have been diagnosed and that may have contributed to the development of the condition can be addressed. This may make postoperative ROM less painful and recovery time decreased. Fig. 1Arthroscopic photo of axillary pouch after manipulation showing thickness of capsule and axillary nerve in a left shoulder

Operative treatment of adhesive capsulitis has been shown to decrease the duration of the disease and to return ROM with good success. Total recovery of pain-free ROM averages 2.8 months (1--6), and time for formal physical therapy averages 2.3 months (2--20) weeks. Forward elevation improved from the average of 92--165° and external rotation with the elbow at the side improved from 12 to 56° in a series of 68 shoulders treated with arthroscopic capsular release \[[@CR61]\]. With the added diagnostic abilities of arthroscopy and the favorable return of ROM that is improved over manipulation alone, arthroscopy should be considered if conservative treatment fails.

Rehabilitation {#Sec14}
==============

Multiple studies have looked at the efficacy of rehabilitation following adhesive capsulitis. A list of randomized controlled, prospective and retrospective clinical trials can be seen in Table [3](#Tab3){ref-type="table"}. In general, most of these studies demonstrate various degrees of improvement in pain scores, ROM, and function following various treatment modes. Table 3Review of trials of rehabilitation following adhesive capsulitisStudy and dateNumber of shouldersDuration of symptomsInterventions and number of treatmentsOutcomes measuredFollow-upFindingsShaffer et al. \[[@CR24]\], 1992622 weeks to 48 monthsPhysical therapy\
Treatment number not reportedROM\
FunctionAve. 7 years50% of patients still had mild pain, stiffness, or both. 60% demonstrated restricted motion in elevation. Marked restriction only occurred in external rotation. Neither subjective nor objective outcomes were related to age, whether dominant or non-dominant extremity was affected, left vs. right, nature of onset, etiology, method of treatment, bilateral involvement or associated medical conditionsDiercks et al. \[[@CR67]\], 2004775 monthsIntensive physical therapy vs. super vised neglectROM\
Function24 monthsPatients treated with supervised neglect, 89% had normal or near normal painless shoulder function as rated by Constant Score \>80. Intensive physical therapy group 63% reached Constant Score \>80. Constant Score at end of study and moment Constant Score reached \>80 seem to indicate supervised neglect yields better outcomes than intensive physical therapyEkelund and Rydell \[[@CR68]\], 19922315 monthsDistension arthrography and manipulation with physical therapy. Treatment number not reportedROM\
Pain48 monthsFollowing treatment rapid improvement seen at 4--6 weeks. 91% of patients had no or slight pain while 83% had normal or near normal range of motionGriggs et al. \[[@CR69]\], 2000779 monthsPhysical therapy passive stretching\
Treatment number not reportedPain\
ROM\
Function22 months90% of patients reported successful outcomes. 10% were not satisfied. Active forward elevation increased 43°, external rotation increased 25°, internal rotation increased 8 vertebral levels, abduction increased 72°. Prior treatment with physical therapy and Workers Compensation claim or pending litigation were associated with need for manipulation or capsular releaseMao et al. \[[@CR70]\], 1997122--12 monthsPhysical therapy 12--18 treatmentsROM2 weeks following arthrogramIn acute patients joint space assessed via arthrography increased significantly after treatment of exercise intervention physical modalities. Joint space most correlated with external rotation and abduction, with less correlation in flexion. In patients no obvious increase in joint space despite increase in shoulder motionMelzer et al. \[[@CR10]\], 199511018 monthsPhysical therapy (89) vs. manipulation (21)Pain\
ROM\
Function3.8 yearsIn those treated with physical therapy abduction increased 78% and anteversion 81%. Least improvement seen in adduction. Subjective personal rating increased 78 points. In the manipulation under anesthesia group range improved greatest in anteversion 73% followed by adduction 62%. Subjective scores only 40 pointsPlaczak et al. \[[@CR71]\], 1998317 monthsManipulation and 14 physical therapy treatmentsPain\
ROM\
Function14 monthsPassive range of motion increased significantly for flexion, abduction, external rotation and internal rotation. Translational manipulation provides a safe, effective treatment option for adhesive capsulitisRoubal et al. \[[@CR72]\], 199687 monthsManipulation and physical therapy 16 treatmentsROM4 weeksFollowing manipulation and physical therapy all active and passive motions increased. Additionally all patients increased in function such as overhead activities, hair care and dressingSharma et al. \[[@CR25]\], 1993329 monthsHydraulic distension and manipulation with 8 weeks of physical therapyROM44 monthsAbduction ROM improved by 46.6° on average, but in 4 patients there was no improvement. Most patients lost some ROM between the 3rd and 5th weekVermeulen et al. \[[@CR73]\], 200078 monthsPhysical therapy with end-range mobilization\
Techniques 2×/week × 3 monthsPain\
ROM9 monthsAfter 3 months there were increases in active range of motion. Mean abduction increased from 96 to 159. Mean flexion increased from 113 to 147. Lateral rotation increased from 13 to 31. Passive range of motion increases included mean abduction from 96 to 159. Mean flexion from 120 to 154. Mean lateral rotation from 21 to 41. Mean capsule capacity increased from 10 cc to 15 cc. Four patients rated shoulder as excellent, two as good and one moderate. All patients maintained joint mobility at the 9 month follow-up

Patient education {#Sec15}
=================

Because adhesive capsulitis is so painful and has a very slow progression of resolution, patient education is critical for success. Patients should be educated in the chronicity of this condition. If they know and understand ahead of time that it can be several years before symptoms are completely resolved, apprehension and a feeling of urgency for functional return may be decreased.

Summary {#Sec16}
=======

Adhesive capsulitis is a common shoulder condition. There is often a delay of patient presentation, and sometimes delay in diagnosis as it can share symptoms with many other shoulder conditions. Typical history is that of minor or no trauma with the gradual progression of pain and loss of ROM. The hallmark of physical examination is loss of both passive and active ROM without degenerative changes on X-ray. A combination of pharmacological, rehabilitative, and/or surgical treatment is commonly helpful for the patient afflicted with adhesive capsulitis. Comorbid factors may play a key role in length and amount of recovery.
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